weight loss/stroke

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention concerns the systemic administration of an inhibitor of fatty acid synthase (E.C. 2.3.1.85, FAS) by any suitable route to achieve weight loss and/or reduction of adipocyte mass without significant toxicity. Use of FAS inhibitors

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to methods for preconditioning and/or providing neuroprotection to the animal central nervous system against ischemia, neurodegeneration, trauma and metal poisoning, including associated cognitive, behavioral and

TECHNICAL FIELD This invention relates to novel compositions with affinity for a monoamine transporter, such as the dopamine, norepinephrine, or serotonin transporter, in brain and in peripheral tissues. BACKGROUND OF THE INVENTION Monoamine transporters play a variety of roles, and compounds with

TECHNICAL FIELD This invention relates to novel compositions with affinity for a monoamine transporter, such as the dopamine, norepinephrine, or serotonin transporter, in brain and in peripheral tissues. BACKGROUND Monoamine transporters play a variety of roles, and compounds with affinity for the

TECHNICAL FIELD This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of

TECHNICAL FIELD This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of

TECHNICAL FIELD This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of newly formed neurons

TECHNICAL FIELD This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of

TECHNICAL FIELD This presently disclosed embodiments relate generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of

TECHNICAL FIELD This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of newly formed neurons

TECHNICAL FIELD This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death. BACKGROUND It is now accepted that the adult vertebrate brain fosters the birth and functional incorporation of newly formed neurons

TECHNICAL FIELD This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death, more particularly use of such compounds as antidepressant agents. BACKGROUND It is now accepted that the adult vertebrate brain fosters

TECHNICAL FIELD This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death, more particularly use of such compounds as antidepressant agents. BACKGROUND It is now accepted that the adult vertebrate brain fosters

TECHNICAL FIELD This invention relates generally to the discovery of pro-neurogenic compounds capable of promoting neurogenesis and/or reducing neuronal cell death, more particularly use of such compounds as antidepressant agents. BACKGROUND It is now accepted that the adult vertebrate brain fosters

FIELD OF INVENTION The present invention relates to a method and a device for controlling an extracorporeal blood treatment apparatus, which can be operated in particular as a hemodialysis apparatus, a hemofiltration apparatus or a hemodiafiltration apparatus. Moreover, the present invention relates